# Neuralink — Healthcare Investment Intelligence

> medical_device · Series D. MedFuel Intel profile as of 2026-06-12.

Neuralink is a neurotechnology company developing implantable brain-computer interfaces (BCIs) to connect human brains directly to computers. Its initial goal is to help people with paralysis control external devices with their thoughts, and it has pursued human clinical trials for its implantable device.

## Key facts (as of 2026-06-12)
- Sector: medical_device
- Stage: Series D
- Website: https://neuralink.com

## MedFuel assessment
- Intelligence score: 0/100
- Analyses: 0
- Sentiment trend: stable

---
Source: MedFuel Intel — https://medfuelintel.com/company/neuralink-36. Figures reflect MedFuel's analysis; verify against primary sources (SEC, FDA, ClinicalTrials.gov) before any investment decision.